批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/07/05 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/21 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE 剂型/给药途径:SYRUP;ORAL 规格:1.5MG/5ML;5MG/5ML 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
088008 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
1983/03/03
|
WOCKHARDT BIO AG |
088017 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
1983/07/05
|
ACTAVIS MID ATLANTIC |
005213 |
002 |
NDA |
HYCODAN |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
Yes |
No |
AA |
1988/07/26
|
GENUS |
040613 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Discontinued |
No |
No |
AA |
2008/02/08
|
GENUS |
203535 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
2017/02/13
|
NOVEL LABS INC |
205731 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
2017/02/15
|
PADAGIS US |
207487 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
Yes |
AA |
2017/02/21
|
ABHAI LLC |